Published in Curr Neurol Neurosci Rep on May 01, 2005
Transgenic mouse models for studying adult neurogenesis. Front Biol (Beijing) (2016) 0.78
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol (2001) 9.04
Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature (2003) 6.35
Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron (2000) 6.33
In vitro differentiation of embryonic stem cells. Curr Opin Cell Biol (1995) 5.56
Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature (2003) 5.31
Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science (1999) 5.13
Induction of neurogenesis in the neocortex of adult mice. Nature (2000) 5.04
Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci (1997) 4.92
Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A (2004) 4.70
Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med (2002) 3.68
TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci (2001) 3.50
Transplantation of cultured human neuronal cells for patients with stroke. Neurology (2000) 3.38
Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis. J Neurosci (1996) 3.31
Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci (2002) 3.28
Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus. J Neurosci (2001) 3.23
Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med (2002) 3.04
Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp Neurol (2002) 2.72
Enrichment of neurons and neural precursors from human embryonic stem cells. Exp Neurol (2001) 2.63
Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc Natl Acad Sci U S A (2000) 2.35
Clonal analysis of oligodendrocyte development in culture: evidence for a developmental clock that counts cell divisions. Cell (1986) 2.31
Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med (2001) 2.27
New concepts in the immunopathogenesis of multiple sclerosis. Nat Rev Neurosci (2002) 2.21
Transplanted bone marrow generates new neurons in human brains. Proc Natl Acad Sci U S A (2003) 2.20
Adenoviral brain-derived neurotrophic factor induces both neostriatal and olfactory neuronal recruitment from endogenous progenitor cells in the adult forebrain. J Neurosci (2001) 1.94
Interleukin-1beta promotes repair of the CNS. J Neurosci (2001) 1.92
Identification of a human olfactory ensheathing cell that can effect transplant-mediated remyelination of demyelinated CNS axons. Brain (2000) 1.85
GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors. Neuron (1996) 1.84
Neural stem cells in the adult human brain. Exp Cell Res (1999) 1.81
Growth factors regulate the survival and fate of cells derived from human neurospheres. Nat Biotechnol (2001) 1.70
Remyelination of the spinal cord following intravenous delivery of bone marrow cells. Glia (2002) 1.68
Multiple sclerosis: remyelination of nascent lesions. Ann Neurol (1993) 1.64
A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain (1999) 1.63
Transplanted olfactory ensheathing cells remyelinate and enhance axonal conduction in the demyelinated dorsal columns of the rat spinal cord. J Neurosci (1998) 1.60
The chemokine system in neuroinflammation: an update. J Infect Dis (2002) 1.57
Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. Arch Neurol (2003) 1.55
Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord. J Neuropathol Exp Neurol (1997) 1.53
In vivo proliferation of oligodendrocyte progenitors expressing PDGFalphaR during early remyelination. J Neurobiol (1998) 1.48
Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc Natl Acad Sci U S A (2000) 1.46
Transplantation of cryopreserved adult human Schwann cells enhances axonal conduction in demyelinated spinal cord. J Neurosci (2001) 1.44
Patterns of oligodendroglia pathology in multiple sclerosis. Brain (1994) 1.44
Bone marrow grafts restore cerebral blood flow and blood brain barrier in stroke rats. Brain Res (2004) 1.40
Human neural stem cell transplants improve motor function in a rat model of Huntington's disease. J Comp Neurol (2004) 1.35
K+ channel distribution and clustering in developing and hypomyelinated axons of the optic nerve. J Neurocytol (2000) 1.23
Targeting of marrow-derived astrocytes to the ischemic brain. Neuroreport (1999) 1.21
Multiple sclerosis: remyelination in acute lesions. J Neuropathol Exp Neurol (1993) 1.20
Oligodendrocytes in the early course of multiple sclerosis. Ann Neurol (1994) 1.18
Dysregulation of axonal sodium channel isoforms after adult-onset chronic demyelination. J Neurosci Res (2003) 1.15
Pattern of remyelination in the CNS. Nature (1974) 1.13
Neural transplantation of human neuroteratocarcinoma (hNT) neurons into ischemic rats. A quantitative dose-response analysis of cell survival and behavioral recovery. Neuroscience (1999) 1.12
Chronic demyelination inhibits remyelination in the central nervous system. An analysis of contributing factors. Lab Invest (1980) 1.12
A pilot study of recombinant insulin-like growth factor-1 in seven multiple sderosis patients. Mult Scler (2002) 1.09
Mechanisms of neural crest cell migration. Bioessays (1993) 1.06
Human antibodies accelerate the rate of remyelination following lysolecithin-induced demyelination in mice. Glia (2002) 1.06
Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system. J Exp Med (2000) 1.06
Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody. J Neuroimmunol (1992) 0.98
Spontaneous remyelination following extensive demyelination is associated with improved neurological function in a viral model of multiple sclerosis. Brain (2001) 0.98
Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease. Nat Med (1998) 0.96
Failure to achieve remyelination of demyelinated rat axons following transplantation of glial cells obtained from the adult human brain. Neuropathol Appl Neurobiol (1996) 0.96
In vivo actions of fibroblast growth factor-2 and insulin-like growth factor-I on oligodendrocyte development and myelination in the central nervous system. J Neurosci Res (1999) 0.89
Autologous haematopoietic-stem-cell transplantation for multiple sclerosis. Lancet Neurol (2005) 0.88
Neuregulin: an oligodendrocyte growth factor absent in active multiple sclerosis lesions. Dev Neurosci (2001) 0.86
Embryonic cultures but not embryos transplanted to the mouse's brain grow rapidly without immunosuppression. Int J Neurosci (1995) 0.84
To what extent is oligodendrocyte progenitor migration a limiting factor in the remyelination of multiple sclerosis lesions? Mult Scler (1997) 0.83
Differential DM20 mRNA expression distinguishes two distinct patterns of spontaneous recovery from murine autoimmune encephalomyelitis. J Neurosci Res (2001) 0.80
Association between integrin-dependent migration capacity of neural stem cells in vitro and anatomical repair following transplantation. Mol Cell Neurosci (2001) 0.80
Placebo controlled pilot trial to study the remyelinating potential of intravenous immunoglobulins in multiple sclerosis. J Neurol Neurosurg Psychiatry (2000) 0.80
Endogenous aFGF expression and cellular changes after a demyelinating lesion in the spinal cord of adult normal mice: immunohistochemical study. J Neurosci Res (1992) 0.78
Transplantation of human fetal striatum into a rodent model of Huntington's disease ameliorates locomotor deficits. Neurosci Res (1996) 0.76
Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell (2010) 4.30
Magnetic resonance spectroscopy identifies neural progenitor cells in the live human brain. Science (2007) 3.96
Neural potential of a stem cell population in the hair follicle. Cell Cycle (2007) 1.53
Multiple white matter tract abnormalities underlie cognitive impairment in RRMS. Neuroimage (2011) 1.19
Introduction of green fluorescent protein (GFP) into hippocampal neurons through viral infection. Cold Spring Harb Protoc (2010) 1.00
Adult human neurogenesis: from microscopy to magnetic resonance imaging. Front Neurosci (2011) 0.98
TM4SF20 ancestral deletion and susceptibility to a pediatric disorder of early language delay and cerebral white matter hyperintensities. Am J Hum Genet (2013) 0.93
Members of the high mobility group B protein family are dynamically expressed in embryonic neural stem cells. Proteome Sci (2013) 0.79
Neurogenic plasticity of mesenchymal stem cell, an alluring cellular replacement for traumatic brain injury. Curr Stem Cell Res Ther (2016) 0.78
Correction: Neuronal Hyperactivity Disturbs ATP Microgradients, Impairs Microglial Motility, and Reduces Phagocytic Receptor Expression Triggering Apoptosis/Microglial Phagocytosis Uncoupling. PLoS Biol (2016) 0.77
Correction: Neuronal Hyperactivity Disturbs ATP Microgradients, Impairs Microglial Motility, and Reduces Phagocytic Receptor Expression Triggering Apoptosis/Microglial Phagocytosis Uncoupling. PLoS Biol (2016) 0.75